Anti-CO2A1/ COL2A1/ ANFH functional antibody

Anti-CO2A1/ COL2A1/ ANFH functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to COL2A1/COL2A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0105-Ab-1/ GM-Tg-hg-SE0105-Ab-2Anti-Human COL2A1 monoclonal antibodyHuman
GM-Tg-rg-SE0105-Ab-1/ GM-Tg-rg-SE0105-Ab-2Anti-Rat COL2A1 monoclonal antibodyRat
GM-Tg-mg-SE0105-Ab-1/ GM-Tg-mg-SE0105-Ab-2Anti-Mouse COL2A1 monoclonal antibodyMouse
GM-Tg-cynog-SE0105-Ab-1/ GM-Tg-cynog-SE0105-Ab-2Anti-Cynomolgus/ Rhesus macaque COL2A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0105-Ab-1/ GM-Tg-felg-SE0105-Ab-2Anti-Feline COL2A1 monoclonal antibodyFeline
GM-Tg-cang-SE0105-Ab-1/ GM-Tg-cang-SE0105-Ab-2Anti-Canine COL2A1 monoclonal antibodyCanine
GM-Tg-bovg-SE0105-Ab-1/ GM-Tg-bovg-SE0105-Ab-2Anti-Bovine COL2A1 monoclonal antibodyBovine
GM-Tg-equg-SE0105-Ab-1/ GM-Tg-equg-SE0105-Ab-2Anti-Equine COL2A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0105-Ab-1/ GM-Tg-hg-SE0105-Ab-2; GM-Tg-rg-SE0105-Ab-1/ GM-Tg-rg-SE0105-Ab-2;
GM-Tg-mg-SE0105-Ab-1/ GM-Tg-mg-SE0105-Ab-2; GM-Tg-cynog-SE0105-Ab-1/ GM-Tg-cynog-SE0105-Ab-2;
GM-Tg-felg-SE0105-Ab-1/ GM-Tg-felg-SE0105-Ab-2; GM-Tg-cang-SE0105-Ab-1/ GM-Tg-cang-SE0105-Ab-2;
GM-Tg-bovg-SE0105-Ab-1/ GM-Tg-bovg-SE0105-Ab-2; GM-Tg-equg-SE0105-Ab-1/ GM-Tg-equg-SE0105-Ab-2
Products NameAnti-COL2A1 monoclonal antibody
Formatmab
Target NameCOL2A1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-COL2A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0105-Ag-1Recombinant multi-species CO2A1/ COL2A1/ ANFH protein


    Target information

    Target IDGM-SE0105
    Target NameCOL2A1
    Gene ID1280,12824,25412,704851,403826,101087493,407142,791241
    Gene Symbol and SynonymsANFH,AOM,CB11,CG2A1A,COL11A3,Col2,Col2a,Col2a-1,COL2A1,COLLII,Del1,Dmm,Lpk,M100413,Rgsc413,Rgsc856,SEDC,STL1
    Uniprot AccessionP02458,P05539,P02459
    Uniprot Entry NameCO2A1_HUMAN,CO2A1_RAT,CO2A1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseRheumatoid vasculitis with rheumatoid arthritis, Osteoarthritis
    Gene EnsemblENSG00000139219
    Target ClassificationN/A

    The target: COL2A1, gene name: COL2A1, also named as ANFH, AOM, COL11A3, SEDC, STL1. This gene encodes the alpha-1 chain of type II collagen, a fibrillar collagen found in cartilage and the vitreous humor of the eye. Mutations in this gene are associated with achondrogenesis, chondrodysplasia, early onset familial osteoarthritis, SED congenita, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome type I, and spondyloepimetaphyseal dysplasia Strudwick type. In addition, defects in processing chondrocalcin, a calcium binding protein that is the C-propeptide of this collagen molecule, are also associated with chondrodysplasia. There are two transcripts identified for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.